Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.

The correct Funding statement is: The work is jointly funded by the Medical Research Council (MRC) UK and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreements (G1001757 and MR/N023668/1); National Institutes of Health grant P01 AI100657; National Institutes of Health grant UM1-AI100645 to the Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID) - subcontract 210782; National Institutes of Health contract HHSN27201100016C; the European Union's Horizon 2020 research and innovation programme under grant agreement No 681137; T.H. and Q.S. are the Jenner Institute Investigators, and Q.S. is a James Martin Senior fellow. Reference 1 Capucci S, Wee EG, Schiffner T, LaBranche CC, Borthwick N, Cupo A, et al. (2017) HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers. [Extracted from the article]